Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1

Interventions

Specimen Handling 273 Magnetic Resonance Spectroscopy 226 pembrolizumab 218 Carboplatin 174 Biopsy 164 Cisplatin 157 Nivolumab 155 Cyclophosphamide 139 Radiotherapy 121 Paclitaxel 120 Gemcitabine 113 durvalumab 90 Bevacizumab 89 Dexamethasone 82 Rituximab 81 Oxaliplatin 77 venetoclax 73 atezolizumab 70 Doxorubicin 70 Docetaxel 66 Radiosurgery 65 Fluorouracil 65 Ipilimumab 64 Capecitabine 64 Etoposide 62 Radiation 59 Prednisone 59 Cytarabine 59 Lenalidomide 56 fludarabine 53

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Inhalation × 90 days × Clear all

NCT04481035 2026-04-21

NF1NAC

Children's Hospital Medical Center, Cincinnati

Phase 2 Completed

5 enrolled 10 charts

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡